Actavia Life Sciences, Inc. (RASP)
OTCMKTS
· Delayed Price · Currency is USD
0.0040
-0.0285 (-87.69%)
At close: Jul 22, 2024
Actavia Life Sciences Statistics
Total Valuation
RASP has a market cap or net worth of 3.09 million. The enterprise value is 3.39 million.
Market Cap | 3.09M |
Enterprise Value | 3.39M |
Important Dates
The last earnings date was Tuesday, February 18, 2025.
Earnings Date | Feb 18, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
RASP has 771.81 million shares outstanding.
Current Share Class | 771.81M |
Shares Outstanding | 771.81M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 0.02% |
Owned by Institutions (%) | 85.19% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | -1.42 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -8.34 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
Current Ratio | 0.02 |
Quick Ratio | 0.00 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -5.54 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -427.68% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 15.83% |
Revenue Per Employee | n/a |
Profits Per Employee | -406,646 |
Employee Count | 1 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.94% in the last 52 weeks. The beta is -81.43, so RASP's price volatility has been lower than the market average.
Beta (5Y) | -81.43 |
52-Week Price Change | -83.94% |
50-Day Moving Average | 0.02 |
200-Day Moving Average | 0.08 |
Relative Strength Index (RSI) | 45.25 |
Average Volume (20 Days) | 14,416 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -345,267 |
Pretax Income | -406,646 |
Net Income | -406,646 |
EBITDA | n/a |
EBIT | -345,267 |
Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 1,392 in cash and 303,962 in debt, giving a net cash position of -302,570 or -0.00 per share.
Cash & Cash Equivalents | 1,392 |
Total Debt | 303,962 |
Net Cash | -302,570 |
Net Cash Per Share | -0.00 |
Equity (Book Value) | -2.18M |
Book Value Per Share | -0.00 |
Working Capital | -2.18M |
Cash Flow
Operating Cash Flow | -66,444 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
RASP does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -186.81% |
Shareholder Yield | -186.81% |
Earnings Yield | -13.17% |
FCF Yield | n/a |
Stock Splits
The last stock split was on September 20, 2016. It was a forward split with a ratio of 3.25.
Last Split Date | Sep 20, 2016 |
Split Type | Forward |
Split Ratio | 3.25 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |